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April 12, 2011:1634–9were a powerful risk stratifier for cardiac death, resuscitated cardiac
arrest, or appropriate implantable cardioverter-defibrillator shock in a
select population. There were 396 patients with frequent premature
ventricular contractions (PVCs [1,000 PVCs in 24 h]) of left bundle
branch block morphology with an inferior QRS axis, all of whom
were said to have normal 12-lead resting electrocardiogram, no family
history of sudden cardiac death (presumably premature sudden cardiac
death), and normal 2-dimensional echocardiograms. The CMR
abnormalities were present in 61 of the 396 patients.
A number of questions remain unanswered by this report. The
normal electrocardiogram was not defined. Does this mean that
none of these patients had T-wave inversion in the precordial leads
beyond V1? It is not stated whether the patients had clinically
nonsustained or sustained ventricular tachycardia with or without
hemodynamic compromise. We find it remarkable that all of
the 396 patients with the above characteristics had normal
2-dimensional echocardiograms even though 126 (32%) had right
ventricular abnormalities detected by CMR, including 43 with
minor right ventricular wall motion abnormalities and 25 with
major wall motion abnormalities (akinesia or bulging) by this
imaging modality. The CMR studies were evaluated by 2 inde-
pendent expert CMR investigators, but there is no mention if there
was similar evaluation of the echocardiograms by experts in
echocardiography. Were quantitative echo data applied to the RV
assessment (such as tricuspid annular plane systolic excursion,
tissue Doppler S’ velocity, fractional area change, or index of
myocardial performance) as recommended by the recent American
Society of Echocardiography guidelines on RV assessment (2)?
The investigators utilized CMR studies to assist in classifying
atients with ventricular tachycardia as to whether right ventricular
ardiomyopathy was present utilizing Task Force Criteria estab-
ished in 1994 (3). In that report, there were no criteria defined for
MR studies for the diagnosis of arrhythmogenic right ventricular
ysplasia/cardiomyopathy (ARVC/D) as this imaging technique
as too new to be evaluated by the Task Force. The recently
ublished guidelines for the diagnosis of ARVC/D should be used
o assess right ventricular abnormalities by CMR (4). These
uidelines do not recognize fatty infiltration. In addition, fatty
nfiltration alone without extensive fibrosis is not a biopsy criterion
or ARVC/D as suggested by the authors.
The message of this paper is that CMR abnormalities alone may
ermit risk stratification of these select patients. The researchers
o not clarify the anatomic views prescribed during the CMR
xamination. Since CMR is used typically as an adjunct to (and
fter) screening echocardiography, it seems more appropriate that
he results of this test are done with dedicated attention to the RV.
n this setting, echocardiography and CMR together are likely to
dd constructively to the diagnosis of ARVC/D, rather than CMR
lone, which may otherwise result in inappropriate diagnosis of
RVC/D (5).
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Reply
We thank Dr. Marcus and colleagues for their interest in our
report (1). In this real-life clinical study, we evaluated the prog-
nostic impact of right ventricular (RV) abnormalities by magnetic
resonance imaging (MRI) in patients with frequent ventricular
premature complexes with left bundle branch morphology.
We excluded patients with other risk factors for arrhythmogenic
right ventricular cardiomyopathy (ARVC): patients had normal
electrocardiogram (also excluding T-wave inversion beyond V1),
normal echocardiogram, and negative maximal exercise test. Pa-
tients with sustained ventricular tachycardia, or nonsustained
ventricular tachycardia and hemodynamic compromise, were ex-
cluded. Patients were enrolled from 2002 and 2005, and echocar-
diogram was performed, but not as prescribed by the recent
guidelines (2): tricuspid annular plane systolic excursion was
calculated in all patients, but tissue Doppler S= velocity, fractional
area change, and other indexes of global RV performance were not
evaluated. However, the majority of patients with RV abnormal-
ities had focal right ventricle involvement (fat or wall motion
abnormalities) and preserved global right ventricle function (aver-
age RV ejection fraction 59  10%); only 6 of them had mild RV
ysfunction (mean ejection fraction 43%). Thus, the evaluation of
egional right ventricle function was determinant for the prognosis.
Cine MRI images were acquired covering the entire right
entricle without gap from diaphragm to the outflow tract in axial
iews and from the right atrium to the cardiac apex in short-axis
iews. In the recent Task Force criteria, the diagnostic accuracy of
RI for the diagnosis of ARVC was evaluated in a population of
62 healthy controls and 44 probands. Probands had an average
V ejection fraction of 43%, suggesting a global RV dysfunction
nd a more advanced stage of ARVC than in our study (3). We
elieve that the main advantage of MRI over other techniques is its
igher accuracy for detecting regional RV abnormalities even when
he global right ventricle function is preserved. This was clinically
elevant because, as it was demonstrated, the risk of sudden death
ith this cardiomyopathy is significant also in the subclinical phase
hen the fibrofatty infiltration is focal and the function is globally
reserved (4). Taking into account the potential advantages of
RI for assessing regional RV abnormalities, we agree that MRI
hould be performed only after echocardiography and not as an
lternative test in the diagnostic work-flow of ARVC.
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Heat Shock Protein as a
Mediator Between the Effects of
Corticosteroids on Atrial
Fibrillation Recurrence After
Catheter Ablation
Koyama et al. (1) conducted an excellent study on the prevention
of atrial fibrillation recurrence with corticosteroids after radiofre-
quency catheter ablation. However, the mechanism by which a
short course of corticosteroids for 3 days right after catheter
ablation could prevent long-term recurrence of atrial fibrillation
remains unclear and puzzling. Inflammation and atrial remodeling
during the early phase seem to play a role.
In reference to that, I would like to point out that corticoste-
roids could decrease atrial fibrillation recurrence by stimulating the
release of heat shock proteins (HSPs). Corticosteroids induce a
heat stress response with the release of HSPs (2). In an in vitro
model, artificially up-regulating HSP27 protects against atrial
remodeling, which was measured as calcium transient and cell
shortening (3). In a canine model, HSP induction attenuates
tachypacing-induced decreases in the effective refractory period
(ERP) (3). This study also demonstrated that remodeling changes
occur in as little as 4 h of tachypacing (3). In another study,
overexpressing HSP27 significantly reduced tachypacing-induced
myolysis (4).
So far, studies have shown that HSPs have cardioprotective
effects at an in vitro level in an animal model. Altering HSP
expression at a clinical level has not yet been studied, and it is
unclear whether it has any disease modification properties in
patients with atrial fibrillation. Future studies should focus on the
interactions between corticosteroids, HSPs, and the recurrence of
atrial fibrillation after cardioversion and catheter ablation. HSPs
could be a novel target for intervention in atrial fibrillation.*Chee Yuan Ng, MD
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We thank Dr. Ng for his constructive suggestions. Unfortunately,
we did not examine heat shock proteins (HSPs) in our study (1).
However, it is one of the important possible mechanisms that
HSPs induced by corticosteroids could prevent atrial electrical
remodeling through cardioprotective actions.
It is known that inflammatory responses are closely associated with
the occurrence or maintenance of atrial fibrillation (AF). AF occur-
rences are frequently observed after cardiac surgery. A previous study
suggested that inflammatory cytokines such as interleukin-6 (IL-6)
are involved in AF occurrences related to cardiac surgery (2). Halonen
et al. (3) provided strong evidence that short-duration and low-dose
corticosteroid could suppress AF onset after surgery. We believe that
the anti-inflammatory action of corticosteroids is an effective thera-
peutic approach to AF. It is commonly accepted that radiofrequency
catheter ablation is an effective therapeutic option for drug-refractory
AF. As mentioned in our study, catheter ablation procedures for AF
cause relatively large amounts of damage to the atrial tissue due to
radiofrequency energy (1). As a result, the acute inflammatory
response could be evoked after catheter ablation procedures. Very
recently, it was reported that interleukin-6–positive mononuclear cells
are recruited to atrial tissue and involved in the arrhythmogenic
substrate in the human atrium (4). We hypothesized that these
responses could occur in damaged cardiac tissue caused by catheter
ablation. This damage could cause infiltration of inflammatory cells
such as mononuclear cells. Additionally, these inflammatory re-
sponses could cause the electrical and structural remodeling via
pro-inflammatory cytokines after catheter ablation, resulting in
the AF recurrence. One possible mechanism is that corticoste-
roids suppress macrophage migration and its release of pro-
inflammatory cytokine, thus preventing AF recurrence after
catheter ablation.
Mandal et al. (5) provided an interesting study showing that
anti-HSP 65 was an important contributor to the risk of postop-
erative AF. St Rammos et al. (6) reported that atrial HSP levels
negatively correlate with AF incidence after cardiac surgery. These
results suggest that HSPs are an important suppressor of AF after
